Regulation of TGF-beta family signaling by E3 ubiquitin ligases

Yasumichi Inoue1, Takeshi Imamura

  • 1Division of Biochemistry, the Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan.

Cancer Science
|September 24, 2008
PubMed

Insights

E3 ubiquitin ligases regulate transforming growth factor-beta (TGF-beta) signaling by controlling Smad degradation. Dysregulation of these ligases is linked to cancer development and progression.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta) family proteins regulate critical cellular processes like proliferation, differentiation, migration, and apoptosis.
  • Dysregulation of TGF-beta signaling pathways is implicated in various human diseases, notably cancer.
  • TGF-beta signaling involves membrane receptors, intracellular Smad proteins, and the ubiquitin-proteasome system.

Purpose of the Study:

  • To elucidate the role of E3 ubiquitin ligases in regulating TGF-beta family signaling.
  • To identify specific E3 ubiquitin ligases involved in Smad degradation and their impact on TGF-beta pathway activity.
  • To explore the connection between E3 ubiquitin ligase abnormalities and cancer development.

Main Methods:

  • Investigated the function of E3 ubiquitin ligases, including Smad ubiquitin regulatory factors (Smurfs) and Arkadia, in the context of TGF-beta signaling.
  • Examined the mechanisms by which E3 ligases mediate the ubiquitination and degradation of Smad proteins and associated factors (e.g., Smad6, Smad7, c-Ski, SnoN).
  • Analyzed the implications of these regulatory processes for TGF-beta pathway modulation.

Main Results:

  • E3 ubiquitin ligases, such as Smurf1, Smurf2, and Arkadia, play a crucial role in degrading key components of the TGF-beta signaling pathway, including Smad proteins.
  • Smurf1 and Smurf2 facilitate the degradation of inhibitory Smads (Smad6, Smad7) by binding to TGF-beta receptors.
  • Arkadia promotes TGF-beta signaling by inducing ubiquitination and degradation of Smad7 and corepressors c-Ski and SnoN.

Conclusions:

  • The ubiquitin-proteasome pathway, particularly E3 ubiquitin ligases, is a critical regulator of TGF-beta family signaling.
  • Aberrant function of E3 ubiquitin ligases involved in TGF-beta signaling components can contribute to the pathogenesis of various cancers.
  • Targeting E3 ubiquitin ligases may offer potential therapeutic strategies for TGF-beta-related cancers.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...